Original paper
Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
Abstract
With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who received DAA therapy after HCC treatment. We retrospectively reviewed patients with HCV-related HCC in a single medical center, and the outcome of...
Paper Details
Title
Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
Published Date
May 22, 2020
Journal
Volume
15
Issue
5
Pages
e0233212 - e0233212
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History